Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Salexander: Here is my "guess" on LymPro Revenue. I am not really basing it on any data I have evaluated, I am just having fun. Here we go: Q1 2015 - 3 Million; Q2 2015 - 7 Million; Q3 2015 - 15 Million; Q4 - 25 Million. (3 + 7 + 15 + 25 = 50 Million in 2015) I would bet things really ramp up in 2016 and they reach 150 Million, and then it gets crazy from there.

What kind of pop will this "future earnings" do for the "current price?" That is where we need to start speculating. Maybe some MBA types like yourself need to step up here and provide an educated financial basis for our mb speculation?

Assuming 50 Million Revenue for LymPro in 2015 and 150 Million Revenue in 2016, Salexander, what formula would an analyst apply to come up with a net present value for AMBS, based on LymPro? Somehow you'll have to figure in the value of the LymPro partnership and what percentage of the profits they'll take. I think it would be fun to do some financing speculation the way someone like Jason Napodano would.